Victoza 3-PAK 18 MG/3 ML pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FNAHR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,945
Award facts
- Contract value 100% obligated
- $3,945.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen medications. The contract carries a ceiling value of $3,945.42 under a firm fixed-price delivery order structure with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion prime vendor agreement valued through December 2026 that supports the company's role as a critical pharmaceutical distributor for military and federal healthcare systems.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp fulfills federal medical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Victoza delivery represents one of numerous competitively awarded orders under the broader IDC vehicle, demonstrating the company's capability to provide specialized medications including diabetes treatments, neurological drugs, and other pharmaceutical products to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio reflects its significant role in supplying brand-name and generic medications, vaccines, and specialized medical supplies across the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNAHR?
SPE2DB25FNAHR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FNAHR worth?
The government has obligated $3,945 on SPE2DB25FNAHR.
Is contract SPE2DB25FNAHR an order under another contract?
Yes. SPE2DB25FNAHR is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAHR competed?
The extent of competition for SPE2DB25FNAHR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award